Premium

Callio Therapeutics

Singapore

Biotechnology

2 – 10

Only available to subscribers

Callio Therapeutics is developing next-generation, multi-payload antibody-drug conjugates (ADCs) that feature differentiated payload and linker technologies.

Read more ↓
Report
Tired of ads? Enjoy an ad-free experience by signing up.
The company isn't hiring currently. But don't let it stop you.
I'm hiring
I'm open to opportunities

Unlock unlimited company data

Subscribe

As our subscriber, you can search and filter over 100,000 companies for your fundraising, investing, or sales needs.

Just $0.17 per day

Sign up and view for free

Register for a Basic account and view “Callio Therapeutics” profile for free

Our subscriber community includes professionals from these companies:

Similar companies

Formulatrix Indonesia

501 – 1,000 employees

0 job positions

Asa Rén

51 – 200 employees

0 job positions

Nusantics

51 – 200 employees

0 job positions

Imagene Labs

11 – 50 employees

0 job positions

illumina

5,001 – 10,000 employees

0 job positions

EnerGaia

11 – 50 employees

0 job positions

Tired of ads? Enjoy an ad-free experience by signing up.